...
首页> 外文期刊>British Journal of Cancer >Assessment of microsatellite instability status for the prediction of metachronous recurrence after initial endoscopic submucosal dissection for early gastric cancer
【24h】

Assessment of microsatellite instability status for the prediction of metachronous recurrence after initial endoscopic submucosal dissection for early gastric cancer

机译:评估微卫星不稳定性状态以预测早期胃癌内镜下黏膜下剥离术后异时复发

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The technique of endoscopic submucosal dissection (ESD) has been developed for en bloc resection of early gastric cancer (EGC); however, little is known about the risk of metachronous cancer in the remnant stomach after initial ESD. In this study, we investigated the correlation between microsatellite instability (MSI) status and the incidence of metachronous recurrence of gastric cancer. According to the genetic/molecular background determined with MSI status and expression levels of hMLH1 and p53 tumour suppressor, 110 EGCs removed with ESD were subclassified into three groups: the mutator/MSI-type (8%), suppressor/p53-type (45%) and unclassified type (47%). Interestingly, patients with the mutator/MSI-type tumour had a high incidence (67%) of metachronous recurrence of gastric cancer within a 3-year observation after initial ESD, which was significantly higher than those with the suppressor/p53-type and unclassified type tumours (P<0.01). Although we investigated mucin phenotypes, there was no correlation between mucin phenotype and the recurrence of EGC. These findings suggest that subclassification of molecular pathological pathways in EGCs is required for the assessment of patients with a high risk of recurrent gastric cancer. The information delivered from our investigation is expected to be of value for decisions about therapy and surveillance after ESD.
机译:内镜下粘膜下剥离术(ESD)技术已被开发用于早期胃癌(EGC)的整体切除术;但是,对于最初的ESD后残留胃中发生异时性癌症的风险知之甚少。在这项研究中,我们调查了微卫星不稳定性(MSI)状态与胃癌异时复发的发生率之间的相关性。根据MSI状态和hMLH1和p53肿瘤抑制子的表达水平确定的遗传/分子背景,经ESD去除的110个EGCs可分为三类:突变子/ MSI型(8%),抑制子/ p53型( 45%)和未分类类型(47%)。有趣的是,突变型/ MSI型肿瘤患者在首次ESD后3年内观察到胃癌异时复发的发生率很高(67%),显着高于抑制型/ p53型和未分类的肿瘤(P <0.01)。尽管我们研究了粘蛋白表型,但粘蛋白表型与EGC的复发之间没有相关性。这些发现表明,对于胃癌复发风险高的患者,需要对EGC中的分子病理学通路进行亚分类。我们期望从调查中获得的信息对于ESD后的治疗和监测决策具有参考价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号